Average Co-Inventor Count = 1.93
ph-index = 10
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Selecta Biosciences, Inc. (19 from 32 patents)
19 patents:
1. 11779641 - Tolerogenic synthetic nanocarriers for allergy therapy
2. 11717569 - Tolerogenic synthetic nanocarriers
3. 11298342 - Methods providing a therapeutic macromolecule and synthetic nanocarriers comprising immunosuppressant locally and concomitantly to reduce both type I and type IV hypersensitivity
4. 11235057 - Methods for providing polymeric synthetic nanocarriers for generating antigen-specific tolerance immune responses
5. 10668053 - Tolerogenic synthetic nanocarriers to reduce or prevent anaphylaxis in response to a non-allergenic antigen
6. 10441651 - Tolerogenic synthetic nanocarriers for generating CD8+ regulatory T cells
7. 10434088 - Methods related to administering immunosuppressants and therapeutic macromolecules at a reduced pharmacodynamically effective dose
8. 10420835 - Tolerogenic synthetic nanocarriers for antigen-specific deletion of T effector cells
9. 10357483 - Methods comprising dosing combinations for reducing undesired humoral immune responses
10. 10357482 - Methods providing a therapeutic macromolecule and synthetic nanocarriers comprising immunosuppressant locally and concomitantly to reduce both type I and type IV hypersensitivity
11. 10039822 - Method for providing polymeric synthetic nanocarriers for generating antigen-specific tolerance immune responses
12. 10004802 - Tolerogenic synthetic nanocarriers for generating CD8+ regulatory T cells
13. 9993548 - Tolerogenic synthetic nanocarriers for inducing regulatory B cells
14. 9987354 - Tolerogenic synthetic nanocarriers for antigen-specific deletion of T effector cells
15. 9295718 - Tolerogenic synthetic nanocarriers to reduce immune responses to therapeutic proteins